Regulation of mitochondria function by natriuretic peptides

被引:13
作者
Domondon, Mark [1 ]
Nikiforova, Anna B. [1 ,4 ]
DeLeon-Pennell, Kristine Y. [2 ,5 ]
Ilatovskaya, Daria, V [1 ,3 ]
机构
[1] Med Univ South Carolina, Div Nephrol, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA
[4] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia
[5] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC USA
基金
美国国家卫生研究院;
关键词
atrial natriuretic peptide; cGMP; guanylate cyclase; mitochondria; natriuretic peptides; RESPIRATORY-CHAIN; SKELETAL-MUSCLE; PROTEIN-KINASE; NITRIC-OXIDE; COMPLEX-I; CGMP; INHIBITION; METABOLISM; EXPRESSION; CELLS;
D O I
10.1152/ajprenal.00384.2019
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Natriuretic peptides (NPs) are well known to promote renal Na' excretion, counteracting the effects of the renin-angiotensinaldosterone system. Thus, NPs serve as a key component in the maintenance of blood pressure, influencing fluid retention capabilities via osmoregulation. Recently, NPs have been shown to affect lipolysis and enhance lipid oxidation and mitochondrial respiration. Here, we provide an overview of current knowledge about the relationship between NPs and mitochondria-mediated processes such as reactive oxygen species production, Ca2+ signaling, and apoptosis. Establishing a clear physiological and mechanistic connection between NPs and mitochondria in the cardiovascular system will open new avenues of research aimed at understanding and potentially using it as a therapeutic target from a completely new angle.
引用
收藏
页码:F1164 / F1168
页数:5
相关论文
共 53 条
[1]   Cyclic nucleotide imaging and cardiovascular disease [J].
Berisha, Filip ;
Nikolaev, Viacheslav O. .
PHARMACOLOGY & THERAPEUTICS, 2017, 175 :107-115
[2]   Mitochondrial energetics in the kidney [J].
Bhargava, Pallavi ;
Schnellmann, Rick G. .
NATURE REVIEWS NEPHROLOGY, 2017, 13 (10) :629-646
[3]   Metabolic Actions Could Confound Advantageous Effects of Combined Angiotensin II Receptor and Neprilysin Inhibition [J].
Birkenfeld, Andreas L. ;
Adams, Frauke ;
Schroeder, Christoph ;
Engeli, Stefan ;
Jordan, Jens .
HYPERTENSION, 2011, 57 (02) :E4-E5
[4]   RETRACTED: The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells (Retracted article. See vol. 56, pg. NIL_0001, 2008) [J].
Boran, Mariela Susana ;
Baltrons, Maria Antonia ;
Garcia, Agustina .
GLIA, 2008, 56 (04) :394-411
[5]   Anaerobic Glycolysis Maintains the Glomerular Filtration Barrier Independent of Mitochondrial Metabolism and Dynamics [J].
Brinkkoetter, Paul T. ;
Bork, Tillmann ;
Salou, Sarah ;
Liang, Wei ;
Mizi, Athanasia ;
Oezel, Cem ;
Koehler, Sybille ;
Hagmann, H. Henning ;
Ising, Christina ;
Kuczkowski, Alexander ;
Schnyder, Svenia ;
Abed, Ahmed ;
Schermer, Bernhard ;
Benzing, Thomas ;
Kretz, Oliver ;
Puelles, Victor G. ;
Lagies, Simon ;
Schlimpert, Manuel ;
Kammerer, Bernd ;
Handschin, Christoph ;
Schell, Christoph ;
Huber, Tobias B. .
CELL REPORTS, 2019, 27 (05) :1551-+
[6]   Nitric oxide and mitochondria [J].
Brown, Guy C. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :1024-1033
[7]   Mitochondria in Ischemic Heart Disease [J].
Buja, L. Maximilian .
MITOCHONDRIAL DYNAMICS IN CARDIOVASCULAR MEDICINE, 2017, 982 :127-140
[8]   EFFECTS OF SYNTHETIC ATRIAL NATRIURETIC FACTOR ON RENAL-FUNCTION AND RENIN RELEASE [J].
BURNETT, JC ;
GRANGER, JP ;
OPGENORTH, TJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (05) :F863-F866
[9]  
CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
[10]  
Charles AL, 2013, BRIT J SURG, V98, P511